Ignite Creation Date:
2025-12-24 @ 1:38 PM
Ignite Modification Date:
2025-12-27 @ 10:12 PM
Study NCT ID:
NCT04782895
Status:
COMPLETED
Last Update Posted:
2023-06-15
First Post:
2021-02-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Immunogenicity of a Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58)Vaccine(E.Coli) Versus Gardasil®9 in Healthy Females 18-26 Years of Age
Sponsor:
Xiamen University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-14
Start Date Type:
ACTUAL
Primary Completion Date:
2022-05-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07-25
Completion Date Type:
ACTUAL
First Submit Date:
2021-02-25
First Submit QC Date:
None
Study First Post Date:
2021-03-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-14
Last Update Post Date:
2023-06-15
Last Update Post Date Type:
ACTUAL